Microbrush reported on Wednesday the immediate availability of the US FDA-listed, ready-for-use, sterilized, nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.

Manufactured in Grafton, Wisconsin, Microbrush's test swab from soft nylon fibers provides an improved patient experience over 3D-printed swabs. The swabs are individually packaged in a medical-grade pouch and are intended for clinical nasopharyngeal sample collection.

Microbrush is a subsidiary of Young Innovations Inc, a provider of equipment used by dentists, hygienists, dental assistants and consumers.